Page 49 - Michael Erman News Today

By Mrinalika Roy (Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of Nov...

(Reuters) -Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Tuesday voted unanimously to recommend use of Novavax Incs COVID-19 vaccine for individuals aged 18 and above.

(Reuters) - Vaccine maker Novavax on Tuesday said that the U.S. Food and Drug Administration had cleared a lot of its COVID vaccine for release in the...

WASHINGTON — The White House on Tuesday urged Americans over age 50 to get vaccination boosters against COVID-19 as the fast-spreading Omicron BA.5 subvariant…

June 30 (Reuters) - Pfizer Inc PFE.N said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA).

By Michael Erman NEW YORK (Reuters) - The U.S. Food and Drug Administration will not require companies to submit clinical trial data on COVID-19 vacci...

(Reuters) -Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID...

(Reuters) - Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently availa...

By Michael Erman NEW YORK (Reuters) - The U.S. Food and Drug Administration will not require companies to submit clinical trial data on COVID-19 vacci...

(Reuters) -Advisers to the U.S. Food and Drug Administration on Tuesday recommended a change in the design of ...